Ipilimumab for patients with advanced mucosal melanoma.

Postow MA, Luke JJ, Bluth MJ, Ramaiya N, Panageas KS, Lawrence DP, Ibrahim N, Flaherty KT, Sullivan RJ, Ott PA, Callahan MK, Harding JJ, D'Angelo SP, Dickson MA, Schwartz GK, Chapman PB, Gnjatic S, Wolchok JD, Hodi FS, Carvajal RD

Open source

DOI
10.1634/theoncologist.2012-0464
Published
2013 Jun
Container
The oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1634/theoncologist.2012-0464,
  title = {Ipilimumab for patients with advanced mucosal melanoma.},
  author = {Postow MA and Luke JJ and Bluth MJ and Ramaiya N and Panageas KS and Lawrence DP and Ibrahim N and Flaherty KT and Sullivan RJ and Ott PA and Callahan MK and Harding JJ and D'Angelo SP and Dickson MA and Schwartz GK and Chapman PB and Gnjatic S and Wolchok JD and Hodi FS and Carvajal RD},
  year = {2013},
  journal = {The oncologist},
  doi = {10.1634/theoncologist.2012-0464},
  url = {https://doi.org/10.1634/theoncologist.2012-0464}
}

RIS

TY  - JOUR
TI  - Ipilimumab for patients with advanced mucosal melanoma.
AU  - Postow MA
AU  - Luke JJ
AU  - Bluth MJ
AU  - Ramaiya N
AU  - Panageas KS
AU  - Lawrence DP
AU  - Ibrahim N
AU  - Flaherty KT
AU  - Sullivan RJ
AU  - Ott PA
AU  - Callahan MK
AU  - Harding JJ
AU  - D'Angelo SP
AU  - Dickson MA
AU  - Schwartz GK
AU  - Chapman PB
AU  - Gnjatic S
AU  - Wolchok JD
AU  - Hodi FS
AU  - Carvajal RD
PY  - 2013
JO  - The oncologist
DO  - 10.1634/theoncologist.2012-0464
UR  - https://doi.org/10.1634/theoncologist.2012-0464
ER  - 

APA

MA, P., JJ, L., MJ, B., N, R., KS, P., DP, L., N, I., KT, F., RJ, S., PA, O., MK, C., JJ, H., SP, D., MA, D., GK, S., PB, C., S, G., JD, W., FS, H., & RD, C. (2013). Ipilimumab for patients with advanced mucosal melanoma.. The oncologist. https://doi.org/10.1634/theoncologist.2012-0464

Source records